This announcement is a separate document:
海普瑞：深圳市海普瑞药业集团股份有限公司面向专业投资者公开发行公司债券2023年跟踪评级报告
Hepry: Shenzhen Hyperthery Pharmaceutical Group Co., Ltd. publicly issued corporate bonds to professional investors in 2023 tracking rating report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.